Skip to main content
Top

Cancer Causes & Control

Issue 4/1999

Content (10 Articles)

Dietary fat and prostate cancer survival

François Meyer, Isabelle Bairati, Ramak Shadmani, Yves Fradet, Lynne Moore

Risks of breast and endometrial cancer after estrogen and estrogen–progestin replacement

Ingemar Persson, Elisabete Weiderpass, Leif Bergkvist, Reinhold Bergström, Catherine Schairer

Rural physicians' understanding of the state-of-the-art in breast, colon and rectum cancer treatment

Theresa A. Hatzell, Thomas C. Ricketts, Sarah E. Tropman, Electra D. Paskett, M. Robert Cooper

Use of oral contraceptives and endometrial cancer risk (Sweden)

Elisabete Weiderpass, Hans-Olov Adami, John A. Baron, Cecilia Magnusson, Anders Lindgren, Ingemar Persson

Physical activity at age 12 and adult breast cancer risk (United States)

Pamela M. Marcus, Beth Newman, Patricia G. Moorman, Robert C. Millikan, Donna Day Baird, Bahjat Qaqish, Barbara Sternfeld

Influence of chemotherapy on the evaluation of breast cancer–diet link

Silvia Franceschi, Ettore Bidoli, Maurizio Montella, Dino Amadori, Carlo La Vecchia

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine